Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
M.D. Anderson Cancer Center
Columbia University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Targazyme, Inc.
Baylor College of Medicine
M.D. Anderson Cancer Center